Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in INKT — MiNK Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to INKT Full portfolio

Position in INKT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23
-$200 QoQ
Shares Held
2
-90.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 27 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. INKT ranks #400 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in INKT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23 2
2025-12-31 $223 20
2025-06-30 $6,272 849
2025-03-31 $7,326 848
2024-12-31 $7,024 10,079
2024-09-30 $7,899 10,533
2024-06-30 $10,305 10,860
2024-03-31 $10,003 11,017
2023-12-31 $12,331 11,526
2023-09-30 $13,336 12,125
2023-06-30 $57,587 27,423
2023-03-31 $62 33
2022-12-31 $83 32
2022-09-30 $65 31
2022-06-30 $31 22
2022-03-31 $1,001 445
2021-12-31 $5,382 1,207